CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Amphastar Pharmaceuticals Inc Company Snapshot
Amphastar Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amphastar Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Organogenesis Holdings Inc (2020 sales of $338.30 million of which 100% was regenerative medicine), Corcept Therapeutics Incorporated ($353.87 million of which 100% was tion of Pharmaceutical products), and Innoviva Inc ($336.79 million of which 100% was Respiratory Assets).

Sales Analysis. During the first quarter of 2021, sales at Amphastar Pharmaceuticals Inc totalled $103.02 million. This is an increase of 21.6% from the $84.69 million in sales at the company during the first quarter of 2020. Amphastar Pharmaceuticals Inc reported sales of $349.85 million for the year ending December of 2020. This represents an increase of 8.5% versus 2019, when the company's sales were $322.36 million. This was the third consecutive year of growth at Amphastar Pharmaceuticals Inc. Sales of Pharmaceutical saw an increase of 9.7% in 2020, from $302.00 million to $331.37 million. Not all segments of Amphastar Pharmaceuticals Inc experienced an increase in sales in 2020: sales of Api fell 9.2% to $18.48 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Amphastar Pharmaceuticals Inc
  Stock Performance Chart for Amphastar Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 19.92
(Figures in U.S. Dollars)
1 Week 6.0%   13 Weeks -0.3%  
4 Weeks 2.9%   52 Weeks 1.7%  
 
Amphastar Pharmaceuticals Inc Key Data:
  Ticker: AMPH Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 349,846,000
(Year Ending Jan 2021).
Employees: 1,980
  Currency: U.S. Dollars Market Cap: 950,542,620
  Fiscal Yr Ends: December Shares Outstanding: 47,718,003
  Share Type: Common Closely Held Shares: 11,093,368
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.